IDEAS home Printed from
MyIDEAS: Login to save this article or follow this journal

Advertising to the End Consumers by Pharmaceutical Companies: Blessing or Curse

  • Scott Goldberg

    (University of Phoenix, Graduate School of Business Asia Pacific Military Campus, Okinawa, Japan)

Registered author(s):

    The last several years have seen an increase in the number of direct to consumer advertisements by pharmaceutical companies. Direct to Consumer advertisements (DTC) means targeting the end consumer through advertisements on television, radio, in newspapers, magazines, and the Internet. The qualitative study presents data and supports the need for a future quantitative study to ask physicians and consumers their opinions on whether pharmaceutical companies should be allowed to advertise directly to the end consumer. This article reviews the literature on this controversial topic, supporting the need to explore the reserach questions in greater detail. A review of the literature suggests there is financial motivation on the part of the pharmaceutical companies to increase their sales by advertsing directly to the end consumer as opposed to performing an educational service to the consumer.

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

    File URL:
    Download Restriction: no

    File URL:
    Download Restriction: no

    Article provided by Society for the Study of Business & Finance in its journal International Journal of Research in Business and Social Science.

    Volume (Year): 2 (2013)
    Issue (Month): 4 (October)
    Pages: 60-71

    in new window

    Handle: RePEc:rbs:ijbrss:v:2:y:2013:i:4:p:60-71
    Contact details of provider: Postal: Beylikduzu Yerleskesi Beykent, Buyukcekmece-Istanbul, Turkey
    Phone: +90 – 444-1-997 / (5307 or 5482)
    Fax: +90 0212 867 55 66
    Web page:

    More information through EDIRC

    No references listed on IDEAS
    You can help add them by filling out this form.

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    When requesting a correction, please mention this item's handle: RePEc:rbs:ijbrss:v:2:y:2013:i:4:p:60-71. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Senol Emir)

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.